Exchange: NASDAQ·Updated 11:53 AM EDT

HBIO Harvard Bioscience Inc.

$8.07
$0.13
(1.58%)
Today
Reported EarningsAug 11
Mkt Cap$37.33M
Vol5,163.00

About HBIO

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, China, United Kingdom, and Rest of the World. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
48

Neutral Sentiment

How do you feel about HBIO?

Advertisement|Remove ads.